AGM voting results: all 5 resolutions passed with thin margins

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Reaction day

₹10.54

prior close

₹11.05

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-6.3% vs market

Healthcare Service Provider peers, median of 27sector-1.2%-3.8% vs sector

On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 3.8 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.9+1.3-6.3-1.2-3.8

Next day

-4.9+1.1-6.0-0.5-4.4

-6.8-1.7-5.1-2.3-4.6

-5.0-1.5-3.6-0.7-4.3

-3.3-0.6-2.7+0.0-3.4

-2.7-0.4-2.2-2.5-0.2

-1.9-1.4-0.5-0.4-1.5

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Boston Commerce (formerly Boston Bio Systems) held AGM on 30 Sep 2026 via VC. All 5 resolutions passed, but 3 had thin margins: financial statements adoption (51.91 percent), co-auditor and Whole-Time Director appointments (both 51.70 percent). Director Yash Chaudhary re-appointment passed with 99.80 percent. Only 16 public shareholders attended; 0 promoters. Of 1447 total shareholders, participation was very low.

Likely market impact

Thin margins on 3 resolutions and zero promoter attendance signal weak shareholder engagement and possible unrest with management or financials.